AlerSense develops world's first smart airborne allergy and asthma early warning system
Published on January 12, 2016 at 2:12 PM
AlerSense Incorporated has created the world's first smart airborne allergy and asthma early warning system alerting consumers as particles and toxins build. AlerSense™ is an in-home unit when, combined with the mobile app, delivers accurate environmental readings, giving asthma and allergy sufferers precious time to remove themselves from, or alter the environment to possibly mitigate or avoid an allergy or asthma attack. AlerSense™ delivers precise in-home measurements of airborne contamination and toxins such as pollen, mold, dust, dust mite waste, VOC's and animal dander helping consumers monitor the levels of airborne contamination in the environment that can cause allergy and asthma attacks. AlerSense™ also tracks humidity and temperature thus creating a holistic air quality assessment.
AlerSense™ was founded by a team of passionate people who were determined to change the way we look at allergies and asthma caused by airborne contaminants. "For the longest time we have accepted the fact that allergies and asthma attacks 'just happen'. We wanted to work on a project that would help people throughout the world understand when contaminants are building in the home so that they can make the appropriate adjustments to possibly avoid an allergy or asthma attack," said Skip Sanzeri founder and CEO of AlerSense. "We've combined some of the world's most advanced sensors, with a smart mobile app and extensive software algorithms that will allow users to record allergy and asthma symptoms at the time when they first noticed the symptoms. Our goal is to give consumers enough time to avoid or mitigate an allergy or asthma attack. And the system gets smarter as it learns each family member's sensitivities based on user input. Airborne contaminants are usually invisible to the naked eye and therefore attack unannounced. Well, we're here to make the announcement."
AlerSense™ units will be available in the spring of 2016.
The global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014 (BCC Research). According to the U. S. Center for Disease Control (CDC), it is estimated that 1 in 12 Americans have asthma. Additionally the CDC estimates that 17.6 million Americans were diagnosed with hay fever in the past 12 months.